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Abstract
Introduction: A hospital-associated outbreak of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was
reported. We aimed to assess the effectiveness of infection control measures among healthcare workers (HCWs)
who were exposed to a MERS patient and/or his body fluids in our institute.
Methods: A descriptive study was conducted among HCWs who worked with a MERS patient in Bamrasnaradura
Infectious Diseases Institute, Thailand, between 18 June and 3 July 2015. Contacts were defined as HCWs who
worked in the patient’s room or with the patient’s body fluids. Serum samples from all contacts were collected
within 14 days of last contact and one month later. Paired sera were tested for detection of MERS‐CoV antibodies
by using an indirect ELISA.
Results: Thirty-eight (88.4 %) of 43 identified contacts consented to enroll. The mean (SD) age was 38.1 (11.1) years,
and 79 % were females. The median (IQR) cumulative duration of work of HCWs in the patient’s room was 35 (20–165)
minutes. The median (IQR) cumulative duration of work of HCWs with the patient’s blood or body fluids in laboratory
was 67.5 (43.7–117.5) minutes. All contacts reported 100 % compliance with hand hygiene, using N95 respirator,
performing respirator fit test, wearing gown, gloves, eye protection, and cap during their entire working period. All
serum specimens of contacts tested for MERS-CoV antibodies were negative.
Conclusions: We provide evidence of effective infection control practices against MERS-CoV transmission in a
healthcare facility. Strict infection control precautions can protect HCWs. The optimal infection control measures for
MERS-CoV should be further evaluated.
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Introduction
Middle East respiratory syndrome (MERS) was first re-
ported in 2012 [1]. Clusters of MERS-Coronavirus
(MERS-CoV) infection have occurred within extended
families, households, and healthcare settings [2]. Human-
to-human transmission has been documented including
transmission to healthcare workers [3–5]. Although the
spread of MERS-CoV is assumed to occur via large
droplets and contact, the possibility of airborne transmis-
sion has not been excluded [6]. Infection prevention and
control guidance for hospitalized patients with MERS
from the US Centers for Disease Control and Prevention
continues to recommend standard, contact, and airborne
precautions. Patients with MERS should be placed in
airborne infection isolation room [7]. A recent study dem-
onstrated that MERS-CoV outbreak was associated with
exposure to healthcare facilities [8]. The number of
healthcare workers (HCWs) acquiring the infection might
have resulted from poor infection control measures [5, 9].
Thus, studies to prevent transmission in healthcare setting
* Correspondence: surasakwiboon@gmail.com
1Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health,
Nonthaburi 11000, Thailand
Full list of author information is available at the end of the article
© 2016 Wiboonchutikul et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wiboonchutikul et al. Antimicrobial Resistance and Infection Control  (2016) 5:21 
DOI 10.1186/s13756-016-0120-9
are critical for the development of control measures. We
aimed to assess the effectiveness of infection control mea-
sures among HCWs who were exposed to a MERS patient
or his body fluids in our institute.
Methodology
On 18 June 2015, the Bamrasnaradura Infectious Diseases
Institute, Ministry of Public Health, Thailand, hospitalized
a laboratory-confirmed case of MERS-CoV infection. The
patient was a 74-year-old man from Oman who had been
admitted to a private hospital 3 days earlier.
The patient had had chest discomfort for one month
before admission to the private hospital. He had progres-
sive dyspnea but did not complain of fever. At the pri-
vate hospital, they found the patient had a temperature
of 38.3°c, and chest radiograph revealed an opacity at
right lung field. A real-time reverse transcription-
polymerase chain reaction (RT-PCR) for MERS-CoV
from nasopharyngeal swab showed a positive result on
17 June 2015 (positive for upE and ORF1a assay).
After the MERS-CoV genome was detected, the pa-
tient was transferred to our institute. Rapid isolation was
done upon receiving the patient. He was placed in an
airborne infection isolation room, and precautions to
prevent airborne and contact transmission were strictly
implemented. Upon the time of admission to our insti-
tute, the patient had a frequent cough and oxygen desat-
uration to 88 %. No fever was detected. He had a
respiratory rate of 28 times/min and crepitation without
wheezing on lung examination. Bilateral interstitial infil-
tration was found on his chest radiograph. Repeated RT-
PCR for MERS-CoV from nasopharyngeal swab was still
positive.
The patient received high flow oxygen and airway care,
including sputum suction. Neither aerosol therapy, nor
non-invasive ventilation or mechanical ventilator was
used. The treatment included intensive care to support
vital organ functions, short course intravenous an-
tibiotics, and a 5-day regimen of oseltamivir. He had a
stable clinical course characterized by improvement in
his oxygenation and resolution of his respiratory symp-
toms. He was discharged home on 3 July 2015 after PCR
for MERS-CoV was negative twice consecutively. Strict
infection control measures were performed until the pa-
tient was discharged from the hospital.
HCWs who were working with the MERS patient and/
or his body fluids were protected by using an N95 res-
pirator that had been fit tested, a gown, disposable
gloves, eye protection, and a disposable cap. Hand hy-
giene was performed before entering and after leaving
the patient’s room or after examining his specimens. The
patient’s body fluids were examined in the laboratory with
a biosafety level 2. Everyone who had been involved with
the patient and/or his body fluids had to sign their names
and duration of working on a timesheet record.
All materials involved in the case were carefully man-
aged. The waste from the patient and soiled linen were
collected in leak-resistant, triple-layered bags. All the ex-
teriors of the bags were disinfected with 70 % alcohol
spray. They were destroyed by incineration. The clean
linen was collected with triple bagging. They were
washed with bleach in a temperature of 70°c for 45 min.
Food utensils and dishware were disposable and man-
aged as infectious waste. For the patient’s room, a 0.05 %
sodium hypochlorite solution was used to disinfect the
room floor daily. The patient’s bed, high-touch surfaces,
and room equipment were cleaned by 70 % alcohol twice
a day. Contaminated sharps were collected in puncture-
resistant containers and incinerated. Clinical specimens
were destroyed by incineration.
The investigation focused on HCWs who had worked
with the MERS patient or his body fluids at Bamrasnara-
dura Infectious Diseases Institute, Thailand, from 18
June through 3 July 2015. The body fluids included
blood, urine, sputum, nasopharyngeal fluid, and other
respiratory secretions. HCWs who had worked in the
patient’s room or with the patient’s body fluids were de-
fined as contacts, and identified by the timesheet re-
cords. All contacts were assessed retrospectively, but
serologic survey was performed prospectively after the
patient was discharged. Demographics, type of contact,
symptoms within 14 days after contact, and adherence
to infection control practices were obtained by question-
naire. Frequency and duration of exposure were re-
trieved from the timesheet records that were signed by
HCWs before and after their works. Serum samples
from all contacts were collected within 14 days of last
contact and one month later.
Paired sera of HCWs were investigated for the MERS‐
CoV antibody by an indirect enzyme-linked immunosorb-
ent assay (EUROIMMUN Medizinische Labordiagnostika
AG, Germany) at Faculty of Medicine Siriraj Hospital,
Mahidol University, Thailand. The assay protocol of the
manufacturer was followed. In brief, a 100 μl volume of the
test serum at dilution of 1: 101 was added onto the wells
coated with purified S1 antigen of MERS coronavirus in du-
plicate. Peroxidase labeled rabbit anti-human IgG was used
as the secondary antibody and tetramethylbenzidine was
used as the substrate. The reaction plate was measured for
optical density by a spectrophotometer using the wave-
lengths of 450 and 630 nm. Positive control, negative con-
trol and calibrator human IgG were included in every
reaction plate to determine the cut-off value for defining
positive, negative or borderline result. Informed consent
was obtained from HCWs. The study was reviewed and ap-
proved by the Bamrasnaradura Institution Review Board.
Results were analyzed by SPSS version 15.0.
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Results
Thirty-eight (88 %) of 43 identified contacts consented
to enroll. The mean (SD) age was 38.6 (11.1) years, and
79 % were females. The most frequently exposed groups
were laboratory personnel (39 %), nurses (21 %), and
radiology technicians (21 %). The most common types
of contact were touching the patient, touching the pa-
tient’s equipment, and examining clinical specimens.
Twenty-one (91 %) of 23 non-laboratory staffs had a dis-
tance of contact with the patient of less than 1 m. The
median (IQR) frequency and median (IQR) cumulative
duration of work of HCWs in the patient’s room were 2
(1–11) times and 35 (20–165) minutes, respectively. The
median (IQR) frequency and median (IQR) cumulative
duration of work of HCWs with the patient’s blood or
body fluids in laboratory were 2 (1–2) times and 67.5
(43.7–117.5) minutes, respectively. All contacts reported
100 % compliance with hand hygiene, using an N95 res-
pirator, performing a respirator fit test, along with wear-
ing a gown, gloves, eye protection, and a cap during
their entire working period (Table 1). Three (8 %) HCWs
developed symptoms after exposure (rhinorrhea in 1,
sore throat in 1, and diarrhea in 1). For the 3 HCWs
who developed diarrhea, rhinorrhea and sore throat, the
first serum sample was collected at day 5, day 10, and
day 12 of their illnesses, respectively. The second sample
was collected at day 35, day 40, and day 41 of their ill-
nesses, respectively. All serum specimens of contacts
tested for MERS-CoV antibodies were negative whereas
those of the patient at day 4, day 9, and day 14 of admis-
sion were all positive.
Discussions
We describe infection control measures and their effect-
iveness among HCWs who were exposed to a MERS pa-
tient or his body fluids in our institute. Hospital
preparedness for receiving MERS patients was designed
and exercised before taking the patient based on the ad-
ministrative control principle. Engineering controls were
established in the airborne isolation unit. Personal pro-
tective equipment was used according to standard, con-
tact and airborne transmission precaution bases. We did
not identify transmission from the patient to any of the
contacts who were adherent to the infection control
practices. This study supports the US Centers for Dis-
ease Control and Prevention recommendations for man-
agement of hospitalized patients with MERS-CoV
infection including implementing standard, contact and
airborne transmission precautions [7]. However, the
World Health Organization has recommended the use
of surgical masks when caring for MERS patients and
particulate respirators for aerosol-generating procedures
[10]. Spread of MERS-CoV has been generally assumed
to occur via large droplets and contact [6]. There has
Table 1 Characteristics of 38 healthcare workers who were
exposed to a MERS patient and/or his body fluids
Characteristics
Gender, n (%)
- Male 8 (21.1)
- Female 30 (78.9)
Age, years (Mean ± SD) 38.6 (11.1)
Staff position, n (%)
- Physician 3 (7.9)
- Nurse 8 (21.1)
- Nursing or patient assistant 3 (7.9)
- Radiology technician 8 (21.1)
- Laboratory personnel 15 (39.4)
- Maid 1 (2.6)
Chronic medical condition, n (%)
- None 28 (73.7)
- Allergy 5 (13.1)
- Hypertension 2 (5.3)
- Dyslipidemia 2 (5.3)
- Diabetes 1 (2.6)
Type of work, n (%)
- With patient 23 (60.5)
- With patient’s blood and body fluids 15 (39.5)
Type of contact, n (%)a
- Touching the patient 19 (50.0)
- Touching the patient’s equipment 19 (50.0)
- Examining clinical specimens 15 (39.5)
- Obtaining clinical specimens 5 (13.2)
- Cleaning the patient’s room 2 (5.3)
Activities with the patient, n (%)a
- Positioning 16 (42.1)
- Examining the patient’s blood or body fluids 15 (39.5)
- Feeding 9 (23.7)
- Bed bathing 8 (21.1)
- Radiography 8 (21.1)
- Assessment of vital signs 7 (18.4)
- Physical examination 6 (15.8)
- Medical or intravenous fluid administration 6 (15.8)
- Airway care 4 (10.5)
- Blood, urine or fecal collection 4 (10.5)
- Linen changing 4 (10.5)
- Nasopharyngeal specimen collection 2 (5.3)
Infection control practices while in contact with the
patient or his blood and/or body fluids, n (%)
- Performing hand hygiene 38 (100)
- Wearing an N95 respirator 38 (100)
- Performing a fit test 38 (100)
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also been a debate on MERS-CoV respiratory precau-
tions [11]. Although our results support the implemen-
tation of airborne transmission precaution, the
understanding of the transmission of MERS-CoV is still
evolving. The best protective strategy against MERS-
CoV should further be assessed.
Some limitations in the study should be acknowl-
edged. First, five contacts denied to participate.
Nevertheless, from the infection prevention and con-
trol unit’s record, none of them developed any symp-
toms within 2 weeks after exposure. Second, the use
of questionnaires might have caused recall bias. Add-
itionally, adherence to infection control practices was
not directly evaluated by observers. However, because
all HCWs were negative for MERS-CoV antibodies,
the effect of recall on the outcome was probably min-
imal. Lastly, because of the language and communica-
tion problems, we were unable to identify the exact
date of illness from the patient or his relatives. None-
theless, RT-PCR for MERS-CoV was still positive
upon the patient’s admission.
We have provided evidence of effective infection con-
trol practices against MERS-CoV transmission in a
healthcare facility. Strict infection control precautions
can protect HCWs. The optimal infection control mea-
sures for MERS-CoV should be further evaluated.
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